N8 Medical N8 Medical
N8 Medical N8 Medical
  • Home
  • About Us
  • Leadership
  • News
  • Technology
    • Overview
    • Publications
  • Pipeline
    • Overview
    • CeraShield™ ETT
    • Additional CeraShield™ Opportunities
  • Contact Us

Andrew Summerfield

N8 Medical > Articles by: Andrew Summerfield

N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant

July 5, 2022 7:17 pmJuly 5, 2022

Read more

N8 Medical News

Here you will find the latest information, including: press releases, events and presentations and blog posts.

Newsletter Sign-up

Interested in hearing whats new with N8 Medical? Sign-up to join our newsletter.

Recent Posts

  • NIH Awards N8 Medical Two Additional SBIR Grants to Develop CeraShieldTM Coated Hemodialysis Catheters and Pedicle Screws
  • N8 Medical Is Awarded Almost $2 Million in Phase II SBIR Grant
  • N8 Medical Announces its CeraShield™ Coating inhibits COVID-19 Virus Growth on Endotracheal Tubes
  • Health Canada Grants Emergency Use Authorization for N8 Medical CeraShield™ Endotracheal Tubes in Mechanically Ventilated COVID-19 Patients
  • Frost & Sullivan awards N8 Medical New Product Innovation Award for its Platform Medical Device Technology to Prevent Hospital-Acquired Infections

N8 Medical, LLC

N8 Medical, Inc. (N8 Medical) is a clinical-stage medical device company focused on commercializing medical devices that incorporate a novel class of active compounds called ceragenins.
The subsidiaries for N8 Medical Inc are N8 Medical, LLC for Medical Device Development and Kinnear Pharmaceuticals, LLC for drug development.
 
  • About Us
  • Leadership
  • News
  • Technology
  • Pipeline
  • Contact Us

© 2019-2023 N8 Medical, LLC. All Rights Reserved. Privacy Policy

Menu
  • Home
  • About Us
  • Leadership
  • News
  • Technology
    • Overview
    • Publications
  • Pipeline
    • Overview
    • CeraShield™ ETT
    • Additional CeraShield™ Opportunities
  • Contact Us